Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

28.38

+0.25

(+0.89%)

At close: 04:00PM EDT

28.53

+0.15

(+0.53%)

After hours:

07:28PM EDT

Loading interactive chart…

Zacks
GMAB vs. CSLLY: Which Stock Is the Better Value Option?
GMAB vs. CSLLY: Which Stock Is the Better Value Option?
GlobeNewswire
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024
Company Announcement Net sales of DARZALEX® in the second quarter of 2024 totaled USD 2,878 millionGenmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; July 17, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as reported by Johnson & Johnson we
Zacks
GMAB or TECH: Which Is the Better Value Stock Right Now?
GMAB vs. TECH: Which Stock Is the Better Value Option?